Journal of Substance Abuse Treatment

Article	Citations
Increased availability of telehealth mental health and substance abuse treatment for peripartum and postpartum women: A unique opportunity to increase telehealth treatment	92
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study	83
Where did the specialty behavioral health workforce grow between 2011 and 2019? Evidence from census data	81
Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic	74
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?	73
The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction	64
Racial disparities in use of non-emergency outpatient care by Medicaid-eligible adults after release from prison: Wisconsin, 2015–2017	62
Employing the Risk-Need-Responsivity (RNR) model and predicting successful completion in an alternative drug court program: Preliminary findings from the Orleans Parish Drug Court	55
Substance use among women who are pregnant: Examining treatment completion by race and ethnicity	55
COVID-19 and treating incarcerated populations for opioid use disorder	47
Effects of a cannabis use disorder text message–delivered treatment on young adult alcohol misuse: Differential effects by gender	46
SMART Recovery International and COVID-19: Expanding the reach of mutual support through online groups	46
C2: editorial board	45
Patterns of enrollment in a New Orleans women's substance use rehabilitation center	45
From there to here: A journey through substance use disorder, prison, and recovery	44
TOC (update)	43
Mapping recovery: A qualitative node map approach to understanding factors proximal to relapse among adolescents in a recovery high school	42
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program	41
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder	39
C2: editorial board	39
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–2020	38
C2: editorial board	37
Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs	36
TOC (update)	36
Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers	35

Variability in outcomes and quality-of-care indicators across clinics participating in a large smoking-cessation program	34
Suicidal behavior, opioid use disorder, and behavioral health treatment: Prevalence and correlates among adults in the United States 2015–2018	33
C2: editorial board	32
A delicate compromise: Striking a balance between public safety measures and the psychosocial needs of staff and clients in residential substance use disorder treatment amid COVID-19	32
Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial	32
JSAT call for papers for special issue: Stimulant use disorder	32
Optimizing outpatient treatment outcomes among methamphetamine-using gay and bisexual men through a computerized depression intervention	31
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine	31
Influence of a national transgender health care directive on receipt of alcohol-related care among transgender Veteran Health Administration patients with unhealthy alcohol use	30
C2: editorial board	29
Rates and predictors of brief intervention for women veterans returning from recent wars: Examining gaps in service delivery for unhealthy alcohol use	29
Opioid-related emergencies in New York City after the Great Recession	28
Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management	28
Characteristics and health care events of patients admitted to treatment for both heroin and methamphetamine compared to patients admitted for heroin only	27
The systematic development of a mobile phone–delivered brief intervention for hazardous drinking in India	27
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program	26
Motivational interviewing telephone counseling to increase postpartum maintenance of abstinence from tobacco	26
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail	25
Mechanisms of change in an adapted marijuana e-CHECKUP TO GO intervention on decreased college student cannabis use	25
Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis	25
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings	25
Poking the bear: The inapplicability of the RNR principles for justice-involved women	24
Public injecting and its association with mental health and other drug-related outcomes among people who inject drugs in Iran	24
Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis	23
Barriers and facilitators of implementing integrated interventions for alcohol misuse and intimate partner violence: A qualitative examination with diverse experts	23
Traditions and Connections for Urban Native Americans (TACUNA): Utilizing community-based input to develop an opioid prevention intervention for urban American Indian/Alaska Native emerging adults	23
Association between discharges against medical advice and readmission in patients treated for drug injection-related skin and soft tissue infections	23
Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma	22
Long-acting depot buprenorphine in people who are homeless: Views and experiences	22
The impact of race, gender, and heroin use on opioid addiction stigma	22
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids	22
Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration	21
Using implementation interventions and peer recovery support to improve opioid treatment outcomes in community supervision: Protocol	21
Law enforcement assisted diversion: Qualitative evaluation of barriers and facilitators of program implementation	21
Contingency management for treatment attendance: A meta-analysis	21
Acceptance of medications for opioid use disorder in recovery housing programs in Missouri	21
The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review	21
Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series	21
A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, he	21
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support	21
Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey	20
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada	20
Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study	20
Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT	20
Digital delivery of a contingency management intervention for substance use disorder: A feasibility study with DynamiCare Health	20
Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees	19
Impacts of COVID-19 on residential treatment programs for substance use disorder	19
The intersection of race and opioid use disorder treatment: A quantitative analysis	19
Racial disparities in linkage to care among patients with substance use disorders	19
Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds	19

Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose	18
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?	18
Predictors and moderators of marijuana and heavy alcohol use outcomes in adolescents treated for co-occurring substance use and psychiatric disorders in a randomized controlled trial	18
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine	18
Race, ethnicity, and emergency department post-overdose care	17
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island	17
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida	17
Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals	17
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic	17
Corrigendum to “Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study” [Journal of Substance Abuse Treatment 130 (2021) 108415]	17
An efficacy trial of adaptive interventions for alcohol use disorder	17
Diagnostic remission of substance use disorders: Racial differences and correlates of remission in a nationally representative sample	17
Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention	17
Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse” [Journal of Substance Abuse Treatment 131 (2021) 108447]	17
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder	17
Substance use and criminogenic thinking: Longitudinal latent class analysis of veterans with criminal histories	16
Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review	16
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19	16
Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services	16
Not in my treatment center: Leadership's perception of barriers to MOUD adoption	16
Goal setting and monitoring with alcohol and other drug use disorders: Principles and practices	16
Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder	16
Clinical symptoms and personality traits predict subpopulations of treatment-seeking substance users	16
Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting	16
Utility of interactive voice response self-monitoring in stabilizing initial change during natural recovery attempts among persons with alcohol use disorder	16
Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review	15
TOC (update)	15
C2: editorial board	15
Post–residential treatment outpatient care preferences: Perspectives of youth with opioid use disorder	15
TOC (update)	15
An intervention pilot to facilitate harm reduction service decentralization in Vietnam	15
Kindness, connection, and science	15
Multimorbidity classes indicate differential patterns of health care engagement among people who inject drugs	15
C2: editorial board	14
TOC (update)	14
TOC (update)	14
A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic	14
Guidelines for authors	14
C2: editorial board	14
Emergency department utilization by individuals with opioid use disorder who were recently incarcerated	14
Sociodemographic and clinical correlates of cannabis dependence among Israeli combat veterans	14
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts	14
Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorder	14
Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care	14
Teaching residents to prescribe buprenorphine for opioid use disorder: Insights from a community-based residency program	14
C2: editorial board	14
COVID-19 surveillance and Black American substance use disorder: An examination of data and policy	14
Beliefs related to health care incentives: Comparison of substance use disorder treatment providers, medical treatment providers, and a public sample	14
Motherhood, substance use and peer support: Benefits of an integrated group program for pregnant and postpartum women	14
Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use	14
Using daily diary methods to understand how college students in recovery use social support	14
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	13
SBIRT administered by mental health counselors for hospitalized adults with substance misuse or disordered use: Evaluating hospital utilization and costs	13
Characterizing nicotine withdrawal in smokers experiencing homelessness	13
Gender differences in patient outcomes following drug abuse treatment in Afghanistan: Results from a new evaluation	13
Adaptations to substance use disorder monitoring by physician health programs in response to COVID-19	13
‘They don't actually join the dots’: An exploration of organizational change in Irish opiate community treatment services	13
TOC (update)	13
Differential impacts of COVID-19 across racial-ethnic identities in persons with opioid use disorder	13
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data	13
C2: editorial board	13
Comparative outcomes for Black children served by the Sobriety Treatment and Recovery Teams program for families with parental substance abuse and child maltreatment	13
The opioid epidemic: Mobilizing an academic health center to improve outcomes	13
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up	12
Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outp	12
Deaths associated with opioids, race and ethnicity, and years of potential life lost in Washington State	12
Internalizing and externalizing subtypes in female patients with co-occurring post-traumatic stress disorder and substance use disorders	12
Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation	12
Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials Network	12
Patterns and contexts of polysubstance use among young and older adults who are involved in the criminal legal system and use opioids: A mixed methods study	12
Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD	12
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic	12
Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic	12
Pre-incarceration polysubstance use involving opioids: A unique risk factor of postrelease return to substance use	12
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic	12
Correlates of disparities in syringe return ratios: A cross-sectional study of a syringe services program in New York	12
Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?	12
Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States	11
The cascade of care for opioid use disorder among youth in British Columbia, 2018	11
Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN)	11

The new services that opioid treatment programs have adopted in response to COVID-19	11
Successful transfer of stable patients on opioid agonist therapies from specialty addiction treatment to primary care settings in Ukraine: A pilot study	11
Integrating substance use care into primary care for adolescents and young adults: Lessons learned	11
Mobile methadone medication units: A brief history, scoping review and research opportunity	11
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis	11
Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19	11
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings	11
Family involvement in treatment and recovery for substance use disorders among transition-age youth: Research bedrocks and opportunities	11
Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities	11
The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial	11
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults	10
Alcohol and drug use among bartenders: An at risk population?	10
Racial inequity in methadone dose at delivery in pregnant women with opioid use disorder	10
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis	10
Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program	10
Developing a cascade of care for opioid use disorder among individuals in jail	10
Corrigendum to “The investigation of the mediating role of coping strategies on the relationship between childhood traumas, depression and alcohol use disorder in university students” [Journal of Subs	10
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)	10
Emergency department–based efforts to offer medication treatment for opioid use disorder: What can we learn from current approaches?	10
Choice of extended release medication for OUD in young adults (buprenorphine or naltrexone): A pilot enhancement of the Youth Opioid Recovery Support (YORS) intervention	10
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders	10
Transporting to treatment: Evaluating the effectiveness of a mobile engagement unit	10
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19	10
Parent SMART (Substance Misuse in Adolescents in Residential Treatment): Pilot randomized trial of a technology-assisted parenting intervention	10
A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations	10
Cascade of care for office-based buprenorphine treatment in Bronx community clinics	10
Parental status and characteristics of women in substance use treatment services: Analysis of electronic patient records	10
Mobile low-threshold buprenorphine integrated with infectious disease services	10
The association between heated tobacco product use and cigarette cessation outcomes among youth smokers: A prospective cohort study	10
“I didn't feel like a number”: The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings	10
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care	9
Episodic future thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability	9
“If I had them, I would use them every time”: Perspectives on fentanyl test strip use from people who use drugs	9
A randomized comparison of 4 vs. 16 weeks of psychosocial treatment for stimulant users	9
Emergency department interventions for opioid use disorder: A synthesis of emerging models	9
Client attitudes toward virtual treatment court	9
Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder	9
“Can we get a Black rehabilitation center”? Factors impacting the treatment experiences of Black people who use opioids	9
A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19	9
A pilot randomized trial of CBT4CBT for women in residential treatment for substance use disorders	9
Housing and supportive services for substance use and self-efficacy among young mothers experiencing homelessness: A randomized controlled trial	9
Patient-centered primary care and receipt of evidence-based alcohol-related care in the national Veterans Health Administration	9
Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic	9
Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives	9
Utilizing patient perception of group treatment in exploring medication adherence, social support, and quality of life outcomes in people who inject drugs with hepatitis C	9
Phenomenological insight into the motivation to quit smoking	9
Psychometric properties of the Anxiety Sensitivity Index-3 in adults with substance use disorders	9
Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015–2016: A multi-method estimation study	9
Associations between relationship quality and treatment-related stress among couples receiving methadone for opioid use disorder	8
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns	8
Treatment preference for opioid use disorder among people who are incarcerated	8
Emergency department presentation of opioid use disorder and alcohol use disorder	8
Participation in methadone programs improves antiretroviral uptake and HIV viral suppression among people who inject drugs in Kenya	8
Treatment outcome and readmission risk among women in women-only versus mixed-gender drug treatment programs in Chile	8
TOC (update)	8
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation	8
TOC (update)	8
Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019	8
Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol	8
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	8
Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year	8
Predictors and outcomes of online mutual-help group attendance in a national survey study	8
TOC (update)	8
A spatio-temporal Bayesian model to estimate risk and evaluate factors related to drug-involved emergency department visits in the greater Baltimore metropolitan area	8
Predictive validity of the New York State Level of Care for Alcohol and Drug Treatment Referral (LOCADTR) for continuous engagement in treatment among individuals recommended for outpatient care	8
C2: editorial board	8
Suicide safer care in behavioral health settings: A comparative analysis of perceptions, training completion, and practice between mental health and substance use disorder treatment providers	8
Differences in electronic cigarette use among adolescents in Korea: A nationwide analysis	8
Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release	8
“Sick and tired of being sick and tired”: Exploring initiation of medications for opioid use disorder among people experiencing homelessness	8
C2: editorial board	8
Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder	8
The association between history of civil commitment for severe substance use and future imprisonment: A Swedish registry study	8
Buprenorphine utilization among all Washington State residents' based upon prescription monitoring program data - Characteristics associated with two measures of retention and patterns of care over ti	8
Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic	7
Prevalence and risk factors for opioid related mortality among probation clients in an American city	7
Validity and item response theory properties of the Alcohol Use Disorders Identification Test for primary care alcohol use screening in Mozambique (AUDIT-MZ)	7
The short-term effectiveness of real-time video counselling on smoking cessation among residents in rural and remote areas: An interim analysis of a randomised trial	7
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration	7
A pilot randomized clinical trial of Brief Behavioral Treatment for Insomnia to reduce problematic cannabis use among trauma-exposed young adults	7
Identifying factors that contribute to burnout and resilience among hospital-based addiction medicine providers: A qualitative study	7
Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders	7
Justice community opioid innovation network (JCOIN): The TCU research hub	7
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study	7
A randomized pilot trial of a mobile phone–based brief intervention with personalized feedback and interactive text messaging to reduce driving after cannabis use and riding with a cannabis impaired d	7
“They went down that road, and they get it”: A qualitative study of peer support worker roles within perinatal substance use programs	7
Education and careers were our way out	7
How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic	7
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use d	7
Disease and decision	7
Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder	7
A Call for Kindness, Connection, and Science	7
The impact of self-help groups on successful substance use treatment completion for opioid use: An intersectional analysis of race/ethnicity and sex	7
Utilization of substance use treatment among criminal justice-involved individuals in the United States	7
Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment	7